Patent details

Basic Information

Publication number:

EP3632439

PCT Application Number:

JP2018020638

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188105787

PCT Publication Number:

WO2018221545

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DEMENTIA THERAPEUTIC AGENT COMBINING PYRAZOLOQUINOLINE DERIVATIVE AND DONEPEZIL

French Title of Invention:

AGENT THÉRAPEUTIQUE POUR LA DÉMENCE COMBINANT UN DÉRIVÉ DE PYRAZOLOQUINOLINE ET DU DONÉPÉZIL

German Title of Invention:

DEMENZTHERAPEUTIKUM, DAS PYRAZOLOCHINOLINDERIVAT UND DONEPEZIL KOMBINIERT

SPC Number:

Dates

Filing date:

30/05/2018

Grant date:

27/03/2024

EP Publication Date:

08/04/2020

PCT Publication Date:

06/12/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/03/2024

EP B1 Publication Date:

27/03/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/05/2024

Expiration date:

30/05/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/03/2024

 

 

Name:

Eisai R&D Management Co., Ltd.

Address:

4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Inventor

1

Name:

KOTANI, Sadaharu

Address:

Japan (JP)

2

Name:

MIYAMOTO, Mai

Address:

Japan (JP)

Priority

Priority Number:

201762513692 P

Priority Date:

01/06/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4745; A61K 31/445; A61P 25/16; A61P 25/28; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202413

Publication date:

27/03/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages